BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6695620)

  • 1. Cerebral blood flow in Parkinson's syndrome.
    Granérus AK; Nilsson NJ; Suurküla M; Svanborg A
    Adv Neurol; 1984; 40():403-5. PubMed ID: 6695620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of regional cerebral circulation in parkinsonism patients according the 133Xe clearance findings].
    Man'kovskii NB; Vanishtok AB; Lizogub VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(1):51-5. PubMed ID: 842227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regional cerebral blood flow in the aging human brain and in Alzheimer's dementia and Parkinson's disease].
    Melamed E
    Harefuah; 1982 Nov; 103(10):234-6. PubMed ID: 7182319
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders.
    Kobari M; Fukuuchi Y; Shinohara T; Obara K; Nogawa S
    J Neurol Sci; 1995 Feb; 128(2):212-8. PubMed ID: 7738597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations made with L-deprenil (Jumex) in the long-term treatment of outpatients with Parkinson's syndrome.
    Gyimóti G; Csanaky A; Leposa D
    Ther Hung; 1983; 31(1):26-30. PubMed ID: 6443750
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperuricemia in Parkinson's syndrome--by chance or probable?].
    Babucke G; Sagebiel L; Mertz DP
    MMW Munch Med Wochenschr; 1976 Nov; 118(46):1489-90. PubMed ID: 825768
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Parkinson's syndrome using a new preparation from the series of tricyclic psychotropic drugs].
    Deze J; Völler GW
    Med Welt; 1975 Aug; 26(33-34):1457-62. PubMed ID: 1100988
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical features of Parkinson's disease in 100 histologically proven cases.
    Hughes AJ; Daniel SE; Lees AJ
    Adv Neurol; 1993; 60():595-9. PubMed ID: 8420197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Crises in the course of Parkinson's disease].
    Danielczyk W
    Wien Med Wochenschr; 1980 Feb; 130(4):149-51. PubMed ID: 7376682
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of dopamine on regional cerebral blood flow in patients with Parkinson's disease before and after L-dopa--measurement by Xe-enhanced CT].
    Aiba I; Indo T; Takahashi A
    Rinsho Shinkeigaku; 1994 Nov; 34(11):1099-104. PubMed ID: 7729088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical-pharmacological basis for the clinical use of L-dioxypheny alanine in Parkinson's syndrome].
    Hornykiewicz VO
    Wien Med Wochenschr; 1975 May; 125(21):325-7. PubMed ID: 1216856
    [No Abstract]   [Full Text] [Related]  

  • 12. Progression and prognosis in Parkinson's disease in relation to concomitant cerebral or peripheral vasculopathy.
    Scigliano G; Musicco M; Soliveri P; Girotti F; Giovannini P; Fetoni V; Caraceni T
    Adv Neurol; 1996; 69():305-9. PubMed ID: 8615143
    [No Abstract]   [Full Text] [Related]  

  • 13. [Generating mechanism and treatment of parkinsonian symptoms].
    Narabayashi H
    Rinsho Shinkeigaku; 1982 Dec; 22(12):1055-62. PubMed ID: 7168940
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group.
    Ann Neurol; 1996 Jan; 39(1):37-45. PubMed ID: 8572664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fracture of the distal end of the femur in Parkinson's disease].
    Ferraro C; Lunardo C; Nolli AL
    Clin Ortop; 1974; 25(3):165-73. PubMed ID: 4471321
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopharmacological study of long-term Jumex + Dopaflex combination treatment in Parkinson's syndrome.
    Antóny M; Tóth G; Széplaki Z
    Ther Hung; 1982; 30(4):168-71. PubMed ID: 6821398
    [No Abstract]   [Full Text] [Related]  

  • 17. Apomorphine increases blood glucose concentrations in Parkinson's disease.
    Tison F; Fouillet N; Henry P
    Clin Neuropharmacol; 1994 Feb; 17(1):92-5. PubMed ID: 8149364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis.
    Nygaard TG
    Adv Neurol; 1993; 60():577-85. PubMed ID: 8420194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cerebral blood flow (CBF) with 133Xe inhalation method--CBF study during CO2 inhalation (author's transl)].
    Kusunoki T; Masumura M; Tamaki N; Matsumoto S; Yamashita H; Hirayama A; Noda S
    No To Shinkei; 1982 Feb; 34(2):131-7. PubMed ID: 6805490
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerebral blood flow and depression].
    Uytdenhoef P; Charles G; Portelange P; Wilmotte J; Mendlewicz J; Jacquy J
    Acta Psychiatr Belg; 1984; 84(2):93-9. PubMed ID: 6741595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.